To evaluate the expression level of MRE11 and CD44 in OSCC patients, we analyzed the two proteins by immunohistochemical staining, which showed that a positive correlation between MRE11 and CD44 protein expression was observed in OSCC tumor tissues (p < 0.001; Figure 1A,B). The gene discussed is CD44; the disease is neoplasm.